Karen Hunsicker, LSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5020 Woodgate Ln, Collegeville, PA 19426 Phone: 610-630-9830 |
Ms. Debra Schroeder Thompson, MSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1214 Hollow Rd, Collegeville, PA 19426 Phone: 610-584-4892 Fax: 610-584-2447 |
Jennifer Ellen Montgomery, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 103 Yorktown Rd, Collegeville, PA 19426 Phone: 610-908-9400 |
Erin Titze, LCSW, M.ED Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3819 Germantown Pike, Collegeville, PA 19426 Phone: 610-910-8886 |
Bernadette M Jackson Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 33 N Grange Ave, Collegeville, PA 19426 Phone: 610-539-0665 Fax: 610-539-6472 |
Christie Aronow, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1015 Bridge Rd, Suite D-2, Collegeville, PA 19426 Phone: 610-639-5393 Fax: 484-971-5911 |
Mrs. Korlu Ezike, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1220 Sugarberry Ln, Collegeville, PA 19426 Phone: 267-246-2687 |
Mr. Phillip Ryan Grant, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 97 Hunt Club Dr, Collegeville, PA 19426 Phone: 610-750-1395 |
Stacy Shuchter-gomez, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 555 2nd Ave, Building D - Suite 202, Collegeville, PA 19426 Phone: 484-973-6661 |
Ms. Elizabeth Anne Millman, MSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 555 2nd Ave, Suite D300, Collegeville, PA 19426 Phone: 610-489-6240 |
Mr. Matthew Scott Ditty, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 555 2nd Ave, Ste D-300, Collegeville, PA 19426 Phone: 610-489-6240 |
News Archive
Bioengineers at the University of California, Berkeley, have shown that physical cues can replace certain chemicals when nudging mature cells back to a pluripotent stage, capable of becoming any cell type in the body.
Senomyx, Inc., a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that Firmenich SA, the world's largest privately-owned fragrance and flavor company, has made a decision to proceed with commercial development of S6973, Senomyx's enhancer of sucrose (table sugar) that has demonstrated the ability to reduce up to 50% of the sugar in a variety of products while maintaining the taste of natural sugar.
This first-in-human study of golodirsen showed its long-term safety and biologic activity in patients with Duchenne Muscular Dystrophy (DMD). The approved exon-skipping therapy is designed to enable the production of functional dystrophin proteins, as described in the peer-reviewed journal Nucleic Acid Therapeutics.
HHS Secretary Mike Leavitt has announced the awarding of $56.9 million by the National Institutes of Health's (NIH) National Center on Minority Health and Health Disparities (NCMHD).
Baxter International Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID 10% [Immune Globulin Infusion (Human)] as a treatment for multifocal motor neuropathy (MMN). This is the first immunoglobulin treatment approved for MMN patients in the United States, and it was approved for use with MMN patients in Europe in 2011.
› Verified 8 days ago